Primoris Wealth Advisors LLC Cuts Stake in The Clorox Company (NYSE:CLX)

Primoris Wealth Advisors LLC decreased its holdings in shares of The Clorox Company (NYSE:CLX) by 15.6% during the third quarter, according to its most recent filing with the SEC. The firm owned 4,508 shares of the company’s stock after selling 831 shares during the period. Primoris Wealth Advisors LLC’s holdings in Clorox were worth $734,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CLX. Nordea Investment Management AB boosted its position in Clorox by 4.5% during the 1st quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock valued at $1,519,000 after acquiring an additional 426 shares in the last quarter. Texas Permanent School Fund Corp grew its stake in Clorox by 1.8% during the 1st quarter. Texas Permanent School Fund Corp now owns 25,636 shares of the company’s stock worth $3,925,000 after buying an additional 455 shares during the last quarter. Empirical Finance LLC increased its position in Clorox by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,457 shares of the company’s stock valued at $682,000 after buying an additional 152 shares in the last quarter. Envestnet Portfolio Solutions Inc. raised its stake in Clorox by 13.3% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 24,567 shares of the company’s stock valued at $3,761,000 after buying an additional 2,880 shares during the last quarter. Finally, Empowered Funds LLC raised its position in shares of Clorox by 8.4% in the 1st quarter. Empowered Funds LLC now owns 20,008 shares of the company’s stock valued at $3,063,000 after purchasing an additional 1,558 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is owned by company insiders.

Clorox Price Performance

Shares of NYSE:CLX traded up $2.39 during midday trading on Friday, reaching $165.16. 1,276,258 shares of the company’s stock traded hands, compared to its average volume of 1,244,660. The company has a fifty day simple moving average of $162.14 and a two-hundred day simple moving average of $146.83. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.09. The company has a market cap of $20.44 billion, a P/E ratio of 57.56, a PEG ratio of 3.02 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 EPS. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. Equities analysts predict that The Clorox Company will post 6.81 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 170.04%.

Wall Street Analyst Weigh In

CLX has been the topic of several research analyst reports. Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their price target for the company from $155.00 to $170.00 in a research note on Wednesday. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. JPMorgan Chase & Co. raised their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, Barclays upped their price target on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat, Clorox has an average rating of “Hold” and an average price target of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.